Figure 1 of Wistow, Mol Vis 2002; 8:185-195.


Figure 1. Sequence of clone bx18g11 for Melastatin 2 (MLSN2)

The full sequence of the clone is shown, together with the ORF (which extends further 5' than that originally proposed for MLSN1). The clone is probably not full length at the 5' end. The polyadenylation signal is shown in red.

   L  R  G  L  L  L  P  V  P  R  I  S  A  Q  A  Q
TGCTCCGGGGACTGCTTTTGCCAGTACCCAGAATCAGTGCTCAGGCTCAG   50
 K  S  W  I  E  R  A  F  Y  K  R  E  C  V  H  I  I
AAATCCTGGATAGAAAGAGCATTTTATAAAAGAGAATGTGTCCACATCAT  100
  P  S  T  K  D  P  H  R  C  C  C  G  R  L  I  G
ACCCAGCACCAAAGACCCCCATAGGTGTTGCTGTGGGCGTCTGATAGGCC  150
Q  H  V  G  L  T  P  S  I  S  V  L  Q  N  E  K  N
AGCATGTTGGCCTCACCCCCAGTATCTCCGTGCTTCAGAATGAGAAAAAT  200
 E  S  R  L  S  R  N  D  I  Q  S  E  K  W  S  I  S
GAAAGTCGCCTCTCCCGAAATGACATCCAGTCTGAAAAGTGGTCCATCAG  250
  K  H  T  Q  L  S  P  T  D  A  F  G  T  I  E  F
CAAACACACTCAACTCAGCCCTACGGATGCTTTTGGGACCATTGAGTTCC  300
Q  G  G  G  H  S  N  K  A  M  Y  V  R  V  S  F  D
AAGGAGGTGGCCATTCCAACAAAGCCATGTATGTGCGAGTATCTTTTGAT  350
 T  K  P  D  L  L  L  H  L  M  T  K  E  W  Q  L  E
ACAAAACCTGATCTCCTCTTACACCTGATGACCAAGGAATGGCAGTTGGA  400
  L  P  K  L  L  I  S  V  H  G  G  L  Q  N  F  E
GCTTCCCAAGCTTCTCATCTCTGTCCATGGGGGCCTGCAGAACTTTGAAC  450
L  Q  P  K  L  K  Q  V  F  G  K  G  L  I  K  A  A
TCCAGCCAAAACTCAAGCAAGTCTTTGGGAAAGGGCTCATCAAAGCAGCT  500
 M  T  T  G  A  W  I  F  T  G  G  V  N  T  G  V  I
ATGACAACTGGAGCGTGGATATTCACTGGAGGGGTTAACACAGGTGTTAT  550
  R  H  V  G  D  A  L  K  D  H  A  S  K  S  R  G
TCGTCATGTTGGCGATGCCTTGAAGGATCATGCCTCTAAGTCTCGAGGAA  600
K  I  C  T  I  G  I  A  P  W  G  I  V  E  N  Q  E
AGATATGCACCATAGGTATTGCCCCCTGGGGAATTGTGGAAAACCAGGAG  650
 D  L  I  G  R  D  V  V  R  P  Y  Q  T  M  S  N  P
GACCTCATTGGAAGAGATGTTGTCCGGCCATACCAGACCATGTCCAATCC  700
  M  S  K  L  T  V  L  N  S  M  H  S  H  F  I  L
CATGAGCAAGCTCACTGTTCTCAACAGCATGCATTCCCACTTCATTCTGG  750
A  D  N  G  T  T  G  K  Y  G  A  E  V  K  L  R  R
CTGACAACGGGACCACTGGAAAATATGGAGCAGAGGTGAAACTTCGAAGA  800
 Q  L  E  K  H  I  S  L  Q  K  I  N  T  R  I  G  Q
CAACTGGAAAAGCATATTTCACTCCAGAAGATAAACACAAGAATCGGTCA  850
  G  V  P  V  V  A  L  I  V  E  G  G  P  N  V  I
AGGTGTTCCTGTGGTGGCACTCATAGTGGAAGGAGGACCCAATGTGATCT  900
S  I  V  L  E  Y  L  R  D  T  P  P  V  P  V  V  V
CGATTGTTTTGGAGTACCTTCGAGACACCCCTCCCGTGCCAGTGGTTGTC  950
 C  D  G  S  G  R  A  S  D  I  L  A  F  G  H  K  Y
TGTGATGGGAGTGGACGGGCATCGGACATCCTGGCCTTTGGGCATAAATA 1000
  S  E  E  G  G  *
CTCAGAAGAAGGCGGGTAGGTAACTTTCCAGGCCCCATGGAAGAACCCTA 1050
AAGCCTGTTTGGAAACGAGGGTATGAGTGGATTATGTTTTCAGTAGCTCA 1100
ACCAAGACCTCAAATCAAAACAAGCTATGAACAAATTGTCTAAAAAATGT 1150
CTGTCATGGGAGGGCTGTGGTGAAGAACAGAGAAACATATTCTAAATGTC 1200
CTGTGAAGTGGGAAATTCTATGAAAGCTACACGGATAATAAAAAGGGTGA 1250
GGAAAAGAAAAAAAAAAAAAAAAA                           1274

Wistow, Mol Vis 2002; 8:185-195 <http://www.molvis.org/molvis/v8/a25/>
©2002 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535